[Therapy of neuroleptic malignant syndrome with dantrolene].
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003620:Dantrolene / Q000627:therapeutic use*; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D008297:Male; D009422:Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy*; D013577:Syndrome
D014150:Antipsychotic Agents; D003620:Dantrolene
Traitement du syndrome malin des neuroleptiques par le dantrolène.